PIETRANGELO, Antonello
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 34.198
EU - Europa 17.881
AS - Asia 17.014
SA - Sud America 2.578
AF - Africa 365
OC - Oceania 71
Continente sconosciuto - Info sul continente non disponibili 22
AN - Antartide 1
Totale 72.130
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 33.650
SG - Singapore 5.231
CN - Cina 4.920
GB - Regno Unito 4.723
IT - Italia 3.686
SE - Svezia 3.391
BR - Brasile 2.026
HK - Hong Kong 1.902
VN - Vietnam 1.765
DE - Germania 1.455
FI - Finlandia 1.246
KR - Corea 849
UA - Ucraina 740
FR - Francia 685
RU - Federazione Russa 610
TR - Turchia 526
IN - India 393
BG - Bulgaria 302
CA - Canada 282
NL - Olanda 265
ID - Indonesia 225
BD - Bangladesh 213
AR - Argentina 199
MX - Messico 156
JP - Giappone 146
IQ - Iraq 141
PL - Polonia 104
ZA - Sudafrica 98
BE - Belgio 91
PK - Pakistan 87
ES - Italia 84
IE - Irlanda 84
AE - Emirati Arabi Uniti 81
MY - Malesia 71
CO - Colombia 69
EC - Ecuador 69
AT - Austria 67
AU - Australia 63
LT - Lituania 62
CL - Cile 60
VE - Venezuela 56
EG - Egitto 52
RO - Romania 49
PH - Filippine 48
CH - Svizzera 40
UZ - Uzbekistan 40
MA - Marocco 39
SA - Arabia Saudita 38
IR - Iran 37
TH - Thailandia 36
DZ - Algeria 34
KE - Kenya 30
PY - Paraguay 30
TN - Tunisia 29
IL - Israele 27
PE - Perù 27
CZ - Repubblica Ceca 26
BO - Bolivia 25
JO - Giordania 25
NP - Nepal 24
GR - Grecia 22
JM - Giamaica 22
OM - Oman 22
CR - Costa Rica 20
KZ - Kazakistan 19
TW - Taiwan 19
PT - Portogallo 18
AZ - Azerbaigian 17
ET - Etiopia 17
HU - Ungheria 17
SI - Slovenia 17
RS - Serbia 15
UY - Uruguay 14
LB - Libano 13
PS - Palestinian Territory 13
SK - Slovacchia (Repubblica Slovacca) 13
HN - Honduras 12
AL - Albania 11
DK - Danimarca 11
SY - Repubblica araba siriana 11
BY - Bielorussia 10
CI - Costa d'Avorio 10
DO - Repubblica Dominicana 10
EU - Europa 10
NG - Nigeria 10
PA - Panama 10
KG - Kirghizistan 9
SN - Senegal 9
CY - Cipro 8
GE - Georgia 8
KH - Cambogia 8
QA - Qatar 8
XK - ???statistics.table.value.countryCode.XK??? 8
AM - Armenia 7
LV - Lettonia 7
TT - Trinidad e Tobago 7
AO - Angola 6
BH - Bahrain 6
MD - Moldavia 6
NZ - Nuova Zelanda 6
Totale 72.015
Salva come PNG Salva come JPEG
Città #
Fairfield 3.380
Ashburn 3.332
Southend 3.205
Singapore 3.180
Santa Clara 2.823
Woodbridge 2.261
Hong Kong 1.877
Hefei 1.857
Stockholm 1.817
Chandler 1.794
Houston 1.792
Jacksonville 1.387
Wilmington 1.152
Seattle 1.143
San Jose 1.127
Cambridge 1.050
Ann Arbor 969
Dearborn 969
Helsinki 956
Chicago 925
London 845
Nyköping 828
Seoul 800
Beijing 785
Ho Chi Minh City 596
Los Angeles 548
Modena 534
The Dalles 477
Hanoi 413
San Diego 372
Council Bluffs 371
Dallas 337
Milan 302
New York 301
Princeton 301
Sofia 279
Eugene 236
Lauterbourg 231
Berlin 211
Buffalo 206
Izmir 204
São Paulo 203
Moscow 193
Shanghai 187
Rome 171
Munich 170
Des Moines 158
Jakarta 153
Redwood City 145
Salt Lake City 142
Bologna 141
Frankfurt am Main 115
Orem 107
Columbus 98
Tokyo 97
Amsterdam 90
Bremen 88
Da Nang 88
Phoenix 81
Warsaw 81
Toronto 78
Falls Church 77
Montreal 72
Brussels 71
Parma 69
Elk Grove Village 68
Porto Alegre 68
Dublin 65
Chennai 64
Philadelphia 63
Rio de Janeiro 62
Ottawa 61
Tampa 61
Brooklyn 60
Yalova 60
Haiphong 59
Kent 58
Boardman 55
Baghdad 54
Nuremberg 53
Johannesburg 52
Nanjing 52
Paris 50
San Francisco 50
Atlanta 48
Florence 48
Guangzhou 48
Mexico City 48
Norwalk 47
Belo Horizonte 46
Turku 45
Denver 44
Fremont 44
Dhaka 43
Brasília 42
Redondo Beach 42
San Mateo 41
Kilburn 38
Manchester 38
Verona 38
Totale 50.863
Salva come PNG Salva come JPEG
Nome #
Alterations in iron status predict cardiac response to blood transfusion in -thalassemia major 1.812
Terapia antialadosteronica e prevenzione della cardiomiopatia cirrotica 702
04093 Portal hypertension in advanced protoporphyric hepatopathy: a case report 478
04092 Liver function, iron status, and hemopoiesis in erythropoietic protoporphyria (EPP): insights into a complex interplay 459
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 448
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with Covid-19 pneumonia. 429
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 423
Coproporphyrin excretion in healthy newborn babies 413
Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene 409
Non-HFE Hepatic Iron Overload. 407
Clinical and molecular epidemiology of erythropoietic protoporphyria in Italy 402
Gluconeogenic Signals Regulate Iron Homeostasis via Hepcidin in Mice. 400
Hereditary hemochromatosis--a new look at an old disease. 397
Unravelling the Complexity of Inherited Retinal Dystrophies Molecular Testing: Added Value of Targeted Next-Generation Sequencing 392
Association between celiac disease and idiopathic dilated cardiomyopathy: a case report. 384
Clinical impact of application of risk assessment models (Padua Prediction Score and Improve Bleeding Score) on venous thromboembolism, major hemorrhage and health expenditure associated with pharmacologic VTE prophylaxis: a “real life” prospective and retrospective observational study on patients hospitalized in a Single Internal Medicine Unit (the STIME study) 381
Impact of safety-related dose reductions or discontinuations on sustained virologic response in HCV-infected patients: Results from the GUARD-C Cohort 379
Ferroportin disease: Pathogenesis, diagnosis and treatment 378
Safety and efficacy of sucrosomal iron in inflammatory bowel disease patients with iron deficiency anemia 376
Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with {NAFLD} 366
Primary hypoparathyroidism is common in adult patients with b-thalassemia and protect patients from osteoporosis. 359
Capitolo 31 "Malattia di Wilson ed emocromatosi", in Sezione V "Malattie del fegato" 355
Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene 352
Human macrophage ferroportin biology and the basis for the ferroportin disease 352
Bone Morphogenetic Protein Signaling Is Impaired in an Hfe Knockout Mouse Model of Hemochromatosis. 352
BMP-6 is a Key Endogenous Regulator of Hepcidin Expression and Iron Metabolism 346
ER stress controls iron metabolism through induction of hepcidin. 344
Hepatitis C virus-induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription 342
Hepcidin expression does not rescue the iron-poor phenotype of Kupffer cells in Hfe-null mice after liver transplantation. 341
Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator. 334
Activin B induces noncanonical SMAD1/5/8 signaling via BMP type I receptors in hepatocytes: Evidence for a role in hepcidin induction by inflammation in male mice 332
First and second wave among hospitalized COVID-19 patients with severe pneumonia: a comparison of 28-day mortality over 1-year pandemic in a tertiary university hospital in Italy. 332
MARKERS OF ENDOTHELIAL DYSFUNCTION AS PREDICTORS OF ASCITIC DECOMPENSATION IN PATIENTS WITH LIVER CIRRHOSIS. 330
Duodenal ferritin synthesis in genetic hemochromatosis 330
An unfortunate case of post-ERCP complications 329
Antiviral treatment profoundly affects iron status in HCV patients: Implications for management and treatment outcome 328
IS FLOW-MEDIATED DILATATION (FMD) ASSESSMENT A RELIABLE MARKER OF ENDOTHELIAL DYSFUNCTION IN LIVER CIRRHOSIS? 328
BMP6 treatment compensates for the molecular defect and ameliorates hemochromatosis in Hfe knockout mice. 324
A Phase 1/2, Dose-Escalation Trial of Deferasirox for the Treatment of Iron Overload in HFE-Related Hereditary Hemochromatosis. 322
Haptoglobin modifies the hemochromatosis phenotype in mice 321
HYPERHOMOCYSTEINEMIA AND MTHFR C677T POLYMORPHISM IN PATIENTS WITH PORTAL VEIN THROMBOSIS COMPLICATING LIVER CIRRHOSIS 321
Hypoxia induced downregulation of hepcidin is mediated by platelet derived growth factor BB 321
Hepatic stellate cells are not subjected to oxidant stress during iron-induced fibrogenesis in rodents 320
Kupffer cells and macrophages are not required for hepatic hepcidin activation during iron overload 319
Comorbidity does not mean clinical complexity: evidence from the RePoSI register 318
The role of the iron responsive element in the control of ferroportin1/IREG1/MTP1 gene expression 317
Juvenile hemochromatosis associated with pathogenic mutations of adult hemochromatosis genes 316
A PAIR OF BROTHERS WITH ACERULOPLASMINEMIA DUE TO A NOVEL NONSENSE MUTATION: UNUSUAL PHENOTYPE AND EFFECTIVENESS OF IRON-CHELATION THERAPY BY DEFERASIROX 315
VITAMIN-E SUPPLEMENTATION PREVENTS HEPATIC CIRRHOSIS DUE TO IRON OVERLOAD IN RODENTS 314
Hepatocellular Carcinoma in HIV-infected Patients: Check Ealy, Treat Hard 314
Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study 314
Iron removal therapy in porphyria cutanea tarda: phlebotomy versus slow subcutaneous desferrioxamine infusion 313
Serum and Liver Iron Differently Regulate the Bone Morphogenetic Protein 6 (BMP6)-SMAD Signaling Pathway in Mice 313
Albumin gene expression is down-regulated by albumin or macromolecule infusion in the rat. 312
ANTIALDOSTERONE THERAPY IN LIVER CIRRHOSIS: A ROLE FOR PREVENTION OF CIRROTHIC CARDIOMIOPATHY? 312
Frequency and biochemical expression of C282Y/H63D hemochromatosis (HFE) gene mutations in the healthy adult population in Italy 310
MOLECULAR AND CELLULAR ASPECTS OF IRON-INDUCED HEPATIC CIRRHOSIS IN RODENTS 307
Heterogeneity of hemochromatosis in Italy 307
DNA repair in lymphocytes from humans and rats with chronic iron overload. 302
The SMAD pathway is required for hepcidin response during endoplasmic reticulum stress 302
3-hydroxy-(4H)-benzopyran-4-ones as potential iron chelating agents in vivo 300
Lipid composition and fluidity of liver plasma membranes from rats with chronic dietary iron overload. 299
Enhanced hepatic collagen type I mRNA expression into fat-storing cells in a rodent model of hemochromatosis. 298
Antialdosterone therapy in liver cirrhosis: a role for prevention of cirrhitc cardiomiopathy ? 298
Haemochromatosis 298
The impact of inherited thrombophilia on liver transplantation. 297
Iron and steatohepatitis. 295
Altered hepatic BMP signaling pathway in human HFE hemochromatosis 295
Hereditary Hemochromatosis: Pathogenesis, Diagnosis, and Treatment 294
Liver gene expression during chronic dietary iron overload in rats 293
Expression of the duodenal iron transporters divalent-metal transporter 1 and ferroportin 1 in iron deficiency and iron overload 291
Excess iron into hepatocytes is required for activation of collagen type I gene during experimental siderosis 291
HIV INFECTION AND SURVIVAL IN PATIENTS WITH HCCAND LIVER CIRRHOSIS 288
Missed treatment in an Italian HBV infected patients cohort: HBV RER 287
Disease progression and liver cancer in the ferroportin disease 284
Hyperhomocysteinemia in patients with acute porphyrias: A potentially dangerous metabolic crossroad? 284
Prevalence Of Subclinical Liver Fibrosis Among Patients With Idiopathic Pulmonary Fibrosis 283
Diacerhein blocks iron regulatory protein activation in inflamed human monocytes 282
Hepatitis B virus DNA integration in tumour tissue of a non-cirrhotic HFE-haemochromatosis patient with hepatocellular carcinoma. 282
Magnetic resonance imaging to identify classic and nonclassic forms of ferroportin disease 282
Prolonged higher dose methylprednisolone vs. conventional dexamethasone in COVID-19 pneumonia: a randomised controlled trial (MEDEAS) 279
Antioxidant activity of silybin in vivo during long-term iron overload in rats 277
Current challenges in the management of patients with sickle cell disease - A report of the Italian experience 277
Genetics, Genetic Testing, and Management of Hemochromatosis: 15 Years since Hepcidin 276
Regulation of transferrin, transferrin receptor, and ferritin genes in human duodenum 273
Hereditary hemochromatosis in adults without pathogenic mutations in the hemochromatosis gene 273
Standard or branched-chain amino acid infusions as short-term nutritional support in liver cirrhosis? 272
MTHFR C677T polymorhism and hyperhomocysteinemia in patients with liver cirrhosis complicated by portal vein thrombosis and hepatocellular carcinoma 272
Modulation of the synthesis of apolipoproteins in rat hepatoma cells. 271
Flow-mediated dilatation (FMD) assessment as a marker of endothelial dysfunction in liver cirrhosis 266
Subclinical liver fibrosis in patients with idiopathic pulmonary fibrosis 265
Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: results from the SIMI-COVID-19 study of the Italian Society of Internal Medicine (SIMI) 263
Huh-7: a human hemochromatotic cell line. 262
THE MOLECULAR BASIS FOR THE HEPATIC REGULATION OF HEPCIDIN, THE IRON HORMONE, BY BONE MORPHOGENETIC PROTEINS. 262
Thyroid volume in adult beta-thalassemic patients is smaller than in controls 261
Serum ferritin as a predictor of treatment outcome in patients with chronic hepatitis C 259
Reducing the risk of hospital admission: A call to action from the Italian Society of Internal Medicine 259
The penetrance of hemochromatosis: mice to the rescue. 258
Lack of enterocyte iron accumulation in the ferroportin disease 258
Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): A structured summary of a study protocol 257
Totale 34.016
Salva come PNG Salva come JPEG
Categoria #
all - tutte 264.187
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 264.187
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021917 0 0 0 0 0 0 0 0 0 0 496 421
2021/20225.494 284 581 517 380 223 271 393 295 619 436 861 634
2022/20235.388 612 563 348 504 647 824 114 592 645 86 244 209
2023/20243.601 169 221 511 298 529 273 301 425 133 188 192 361
2024/202512.875 675 150 341 856 2.182 1.813 773 698 1.227 768 1.768 1.624
2025/202623.810 1.709 1.253 2.283 2.289 2.710 2.089 3.031 1.244 4.417 2.305 480 0
Totale 72.526